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Ankylosing spondylitis (AS) is not fully explained by inﬂammatory processes. Clinical, epidemiological, genetic, and course of
disease features indicate additional host-related risk processes and predispositions. Collectively, the pattern of predisposition to
onset in adolescent and young adult ages, male preponderance, and widely varied severity of AS is unique among rheumatic
diseases. However, this pattern could reﬂect biomechanical and structural diﬀerences between the sexes, naturally occurring
musculoskeletal changes over life cycles, and a population polymorphism. During juvenile development, the body is more
ﬂexible and weaker than during adolescent maturation and young adulthood, when strengthening and stiﬀening considerably
increase. During middle and later ages, the musculoskeletal system again weakens. The novel concept of an innate axial myofascial
hypertonicity reﬂects basic mechanobiological principles in human function, tissue reactivity, and pathology. However, these
processes have been little studied and require critical testing. The proposed physical mechanisms likely interact with recognized
immunobiologicalpathways.Thestructuralbiomechanicalprocessesandtissuereactionsmightpossiblyprecedeinitiationofother
AS-related pathways. Research in the combined structural mechanobiology and immunobiology processes promises to improve
understanding of the initiation and perpetuation of AS than prevailing concepts. The combined processes might better explain
characteristic enthesopathic and inﬂammatory processes in AS.
1.Introduction
Since 1950, ankylosing spondylitis (AS) had been reported to
occur far more prevalently (circa 30 times) among relatives
of spondylitis patients than among control subjects [1]. A
hereditaryriskfactorwasimplicatedbysuchfamilialﬁndings
[1], which have been supported by subsequent studies [2–4].
In 1973, a strong genetic predisposition was conﬁrmed by
the discovery of the remarkably high association of AS with
HLA-B27 [2, 3].
Beside the recently reviewed expanded genetic risks [4],
the multifactorial causation of AS was indicated early by a
deﬁnite male preponderance of clinical disease [5–8]. The
male preponderance was particularly evident among AS
patients who had more severe clinical manifestations [5, 8].
Themale-to-female(M:F)sexratioinAScorrelatesstrongly
with the severity gradient of disease, which varies from 9:1
inthemostprogressivepatientstoafemalepreponderancein
the mildest cases, not explained by presence of the HLA-B27
phenotype [8].
Onset of AS occurs in the ﬁrst decade in less than 10
percent and after the age of 50 years in only 5% or less
[6, 8]. The incidence rate rises sharply in puberty [9]o ra t
about the adolescent age of 15 years, reaches a peak onset in
the early 20s, and decreases before age 35 [8, 10]. Overall,
the characteristic age-speciﬁc onset pattern of AS is little
inﬂuenced by the sex eﬀect [8, 10]. Such risk relations are
consistent with the status of myofascial forces or tonicity in2 Arthritis
thebody,increasingduringadolescentdevelopment,peaking
in early adulthood, and subsequently decreasing with aging.
In the concluding section on Avenues for future research in an
early review [6], the suggestion was raised, “also axial mus-
cle tension may be a factor in these degenerative spinal syn-
dromes”.
The early suspicion that axial myofascial hypertonicity
could predispose to AS [6] has remained consistent with ad-
vances achieved in clinical research, immunogenetics, and
molecular biology [10, 11]. However, the hypothesis has not
yet been directly conﬁrmed, due to lack of reported quan-
titative measurements and research on such mechanisms.
Accordingly, the aims of this paper are to (1) expand upon
our perspectives on the structural biomechanical concept of
AS, (2) integrate mechanobiological pathways with current
inﬂammatory concepts, (3) provide a further rationale for
encouraging such research, and (4) indicate innovative tech-
niques which may oﬀer promise in future investigations to
test the structural biomechanical hypothesis in AS [10].
2.Enthesis-RelatedLesionsas Biomechanical
Linksinthe AnkylosingSpondylitisProcess
In AS, the hallmark localization of pathological lesions is at
entheses[G.en,in,+thesis,aplacing;aninsertion]sites,par-
ticularly in the vertebral spine [11]. Entheses are the attach-
ments or insertions of tendons, ligaments, or joint capsules
into bone [12, 13]. Enthesitis (G. enthetos, implanted, + -itis,
inﬂammation)wasdeﬁned[12]as,“traumaticdiseaseoccur-
ring at the insertion of muscles where recurring concentra-
tion of muscle stress provokes inﬂammation with a strong
tendency toward ﬁbrosis and calciﬁcation.” Enthesopathy
(G. en, in, + thesis,ap l a c i n g ,+pathos,s u ﬀering) was de-
ﬁned [12] as “a disease process occurring at the site of in-
sertion of muscle tendons and ligaments into bones or joint
capsules”. The latter term has gained favor in describing the
manifold processes involving entheses, often due to chronic
mechanical overloading, with or without evidence of inﬂam-
mation [13].
The target enthesis lesions in AS are generally interpreted
to result from inﬂammatory mechanisms associated with
biomechanical stress at the local level [14]. The axial myo-
fascial hypothesis proposes a centralized mechanism for in-
creased tensional stresses in the postural musculoskeletal
anatomy that can transmit excessive forces to entheses in the
spine and girdles [15, 16]. A normally relaxed muscle is
relatively soft and extensible. It can eﬃciently dissipate stress
concentrations by transferring or absorbing them [13]. To
the contrary, stiﬀer muscles less eﬀectively absorb or dis-
tribute forces [13]. Thus, stiﬀer and tenser muscles could
likely transmit greaterstressesto tendons or ligamentsandto
bony enthesis sites, which serve an anchoring role [13, 15].
This perspective concentrates on enthesis lesions in AS,
since they have received greater attention in recent research
[10, 11] than a preceding review of sacroiliac joint (SIJ) in-
volvement [16]. The mechanical principle of integrated
tension (tensegrity) [17–19] is fundamental to the structural
hypothesis. Application of the tensegrity theory to axial
myofascial hypertonicity in the postural system can theo-
retically rationalize concurrently excessive tensional forces
on entheses coexisting with increased compressional loads
across the SIJs [16, 19]. Anatomical cross-bracing of the
dorsal and lateral postural myofascial support systems could
overload the SIJs by increased compressional forces and stiﬀ-
ness (Figure 1)[ 16]. Hypertonicity of the deeper vertebral
myofascial system, like the lumbar multiﬁdus muscles, could
exert its main eﬀects on increased tensional forces at the
spinal entheses and manifest as symptomatic and objective
postural stiﬀness [15].
3. HumanResting Muscle/Myofascial
Tone (HRMT)
Axial or postural human resting muscle/myofascial tone
(HRMT) is an innate polymorphic trait which is indepen-
dent of the central nervous system control and contributes
vitally to stability in balanced equilibrium positions [15, 20,
21]. Increased low-back muscle stiﬀness and tightness in
patients with early AS was ﬁrst reported by Forestier et al. in
1951 [22], which was called the “bowstring sign” [22]. That
observation was subsequently conﬁrmed by palpation and
electromyography studies, as reviewed [23].
The concept of HRMT is believed to incorporate an
innate individual variability (polymorphism), particularly of
the axial postural system [15, 24]. Variability is also likely to
be clinically relevant to proximal limb muscles and girdles,
but less so for the distal extremities. This paper incorporates
HRMT into the biomechanical hypothesis only as related to
theaxialposturalsyst emeﬀectsonvertebralenthesesandthe
SIJs [10, 16].
4. AnEarly HistoricalInterpretation
of ClinicalSyndromes atEnthesisSites
Mechanismscausinglesionsatenthesissitesarecomplex[13,
14]. A paucity of documentation exists on the evolution of
the processes, from initiation, through their course, and into
the later healing stages. The ﬁrst PubMed reference found
on enthesitis was from 1959, titled as “Enthesitis-traumatic
disease of insertions” [25]. The tissue reactions at insertions
were described as follows: “most frequently these stimuli are
of traumatic, particularly microtraumatic, origin. The con-
tinually recurring concentration of muscle stress at these
points provokes a reaction of inﬂammation with a strong
tendency to the formation of ﬁbrosis and calciﬁcation” [25].
5. Evolution of Histological
Featuresin EnthesisLesions: Stages of
Erosion,Then Repair
The earliest pathoanatomical review of enthesopathy found
in PubMed was from 1966 [26], which included description
of both peripheral ligamentous and vertebral lesions. The
enthesis was referred to as a unit [26] and is now referenced
asanorgan[13,27].TheenthesisunitwasdeﬁnedasaspecialArthritis 3
Figure 1: Posterior anatomical relations of the lumbopelvic region.
On the left side, the upper window shows the sacroiliac joint (SIJ).
The lower window shows how the hip joint is interposed between
posterior cross-braced muscles and how the pelvis is stabilized. The
right side shows the attachment of the hamstrings (particularly the
biceps tendon) to the sacrotuberous ligament. The arrow indicates
the long dorsal sacroiliac ligament (LDSIL). Axial myofascial hyper-
tonicity could theoretically exert increased compressional forces on
thepelvis,SIJs,andhips.(Theoriginalwas publishedasFigure 14.4
in [16], In: A. Vleeming, V. Mooney, R. Stoeckart, eds. Movement,
Stability, and Lumbopelvic Pain: Integration of Research and Ther-
apy. Edinburgh, Scotland: Churchill Livingston; 2007:205–227,
reproduced with permission from Churchill Livingston, Copyright
Elsevier, 2011).
anatomical formation consisting of (1) a speciﬁcally struc-
tured part of the bone, (2) the transitional part of the ten-
don, and (3) interpolated ﬁbrocartilage, which is partially
calciﬁed [26]. This deﬁnition has essentially held true [13,
27].Anabsenceofperiosteumattheinsertionsitesoftendon
was emphasized as well as an exceptionally great strain at the
terminal part of the tendon [26]. A metaplastic process was
described at the insertional zone that was considered to be
a possible adaptive manifestation to “one-sided overstrain.”
Often, the alterations included concurrent inﬂammatory
changes and new bone formation, as in a reparative hyper-
plastic stage [26].
This group [26] described localized granular inﬂamma-
tory changes in loose, richly vascularized areolar tissue of the
ligamentous enthesis. At this stage, the localized bone cortex
had become thinned and manifested marginal defects [26].
These ﬁndings were considered to be the destructive (ero-
sive) phase of enthesitis. Notably, reparative changes were
observed along with the destructive ones. In the advanced
stage, typical ossifying enthesitis (enthesophyte) had devel-
oped [26].
6.EnthesisLesions inAnkylosingSpondylitis
The classical reported pathoanatomical ﬁndings in AS pa-
tients are almost uniformly restricted to advanced stages in
the available tissue materials, usually in late and post-mor-
tem stages [28–32]. Initial lesions of the local processes are
hardly documented [29].
TheclassicalpaperonenthesopathyinASwasthesubject
of the Heberden Oration, 1970 [31]. Firstly, Ball [31]c o m -
pared rheumatoid spondylitis (RS), mainly deﬁned from
early cervical involved cases, to the histopathology of late AS
spondylitis. In the cervical RS cases, instability and disloca-
tion were stated to be associated with erosive synovitis of the
apophyseal joints and to be associated with destructive
lesions of the corresponding disc [31]. The enthesopathy of
RS occurred in the annulus ﬁbrosus of cervical discs and was
considered to be secondary to the primary synovitis. It was
not associated with prominent reactive bone formation, as
was found in AS [31]. Immobilization was considered as a
mechanism in the prominent enchondral ossiﬁcation feature
in AS, which occurs in the apophyseal joints [31].
Secondly, Ball [31] examined extraspinal ligamentous
lesions of AS in mainly biopsy specimens. Like Niepel et al.
[26], the striking ﬁndings were multiple focal microscopic
inﬂammatory lesions localized to the ligamentous attach-
ments [31]. The whole or greater part of the enthesis was
destroyed in association with small erosions or defects in
the cortical bone. The inﬂammation reaction was considered
briefinindividual lesions,mostlyinvolving lymphocytesand
plasma cells [31]. The erosive lesions healed by deposition
of reactive (woven) bone in a ﬁnely ﬁbrous connective tissue
withoutprecedingcartilageformation.Thenewbonetended
to ﬁll in the cortical defect as well as having joined the
deeperbonetotheerodedendoftheligament.Thenewbone
formed a new enthesis above the original level of the cortical
surface. In the ﬁnal healing stage, it appeared as a small ir-
regular bony prominence [31].
7. IntervertebralDisc Lesions in
AnkylosingSpondylitis
According to Ball [31], the concept that ossiﬁcation of the
intervertebral discs in AS is inﬂammatory in origin may be
traced back to Engfeldt et al. [28]a n dt oB y w a t e r s[ 29, 30].
Currently, inﬂammation is still considered to be essential to
the pathogenesis of AS [10, 11]. Ball [31] interpreted the
spinal lesions from 13 necropsy specimens, 12 having de-
ceasedafter12 to 33 yearsfollowingonset of AS.The lateand
somewhat fragmentary nature of the spinal specimens was
acknowledged [31].
Ball [31] found erosive lesions at the anterior or antero-
lateral attachments of the outer ﬁbers of the annulus at the
corner of the vertebral body and at the junction of the annu-
lar ﬂange. Inﬁltration of lymphocytes and plasma cells was4 Arthritis
scanty in some and prominent in other lesions. Of note, the
common longitudinal ligament was conspicuously unaﬀect-
ed in anterior lesions. In the area of the erosive lesions, the
vertebral cortex was replaced by a narrow layer of reactive
bone that spread for a short distance into the outer annulus,
that is, the disc syndesmophyte. The process involved the
replacement and remodeling of the reactive bone into
mature (lamellar) bone. Ball [31] tentatively interpreted a
mechanism for the growth of disc syndesmophytes as “the
intermittent occurrence of inﬂammatory lesions in previ-
ously stable syndesmophytes.” Our tentative biomechanical
interpretation of this process might be that an inﬂammatory
phase, possibly contributed by microinjury, precedes the
ossiﬁcation (healing) or syndesmophyte (immobilization)
stage.
Lastly, Ball [31] considered the ossiﬁcation process in
the apophyseal joints. In two AS cases, capsular ossiﬁcation
occurred in the setting of doubtful erosive synovitis and with
preserved articular cartilages. The capsular ﬁndings were
interpreted as equivalent to syndesmophyte formation and
that the enclosed articular cartilages were being replaced by a
nonspeciﬁc process of enchondral ossiﬁcation [31].
In subsequent reviews of the articular pathology of anky-
losing spondylitis, Ball [32–34] raised the possibility that
inﬂammatory enthesopathy was not the only mechanism
that may give rise to syndesmophyte formation. This process
can be attributed to implied immobilization and changes in
load transmission across the disc [33]. Destructive spondy-
lodiscitis lesions were also reviewed in the later articles
[32,33],whichhadnotbeenearlierconsidered[31].Clinical,
radiological, and pathological evidence indicated that these
destructive spondylodiscitis lesions are essentially owing to
trauma in a spine that for various reasons is susceptible to
stress [32, 33]. Controversy exists, however, regarding an
interpretation of the variable histopathology of the spondy-
lodiscitis lesions, which may not show inﬂammatory inﬁltra-
tion [32, 33].
8.ANovelBiomechanical
Interpretationof ClassicalHistological
Studiesof EnthesisLesions
Injury mechanisms from structural impacts were only later
considered by Ball [32, 33]. Microinjury was not addressed
in relation to causing erosive lesions at the attachment sites
of the annulus ﬁbrosus to the vertebral margins, at which
syndesmophytes start to grow [31, 32]. Modern biomechan-
ical research has established that this disc-vertebral interface
is subjected to increased localized force concentrations at its
outer circumferential boundaries in the spine [35].
Further research into the indicated diﬀerential involve-
ment of the lumbar anterior longitudinal ligament (ALL)
versus the disc entheses in AS [28, 31] could potentially clar-
ifymechanisticpathwaysinsyndesmophyteformation.Man-
y reports stated that the anterior ossiﬁcation between the
vertebral bodies is not situated in the ALL, but rather in the
periphery of the disks [28, 31]. Both tissues are in close prox-
imity to the cellular inﬁltrations and new bone formation at
the edge of the annulus [31, plate 3(a)]. A hypothetical ques-
tion might be raised as follows. Could diﬀerential degrees of
mechanically induced microinjury, in one versus the other
tissue, lead to the observed diﬀerences in inﬂammatory reac-
tions? If so, might such mechanisms inﬂuence later bony
proliferation leading to diﬀerential involvements in syn-
desmophyte formation? Such biomechanical issues had not
been raised in the classical papers [28–33] nor have we en-
countered them in the current literature.
9.ParallelsinTendinopathy and
AnkylosingSpondylitisEnthesisLesions
Tendinopathy is currently considered to be mainly nonin-
ﬂammatory (enthesopathy) [13, 36, 37], whereas AS is
thought to have a primarily inﬂammatory cause (enthesitis)
[11]. Mechanical overloading is believed to be the primary
initiating pathology in degenerative and overuse tendinopa-
thy [38, 39]. Like AS [40], many tendinopathies are inser-
tionalinnature,havingadiseaselocalizationatenthesissites,
where the tendon or ligament attaches to bone [37]. One
may question if the pathways leading to these conditions
might be more similar than previously believed. Might bio-
mechanical stress mechanisms also be an important predis-
posing pathway in AS?
Histopathological studies of the Achilles tendinopathy
aretypicallycharacterizedbyalackofinﬂammatorycellsand
other evidence for inﬂammatory mechanisms [13, 41, 42].
Rather,theyshowapoorhealingresponse,involvingcollagen
ﬁber disorientation, tenocyte hypercellularity, neovascular-
ization, and neurovascular ingrowth [38, 42]. Calciﬁcation
and osseous metaplasia can also be found in symptomatic
tendons [38]. A primarily noninﬂammatory mechanism is
also endorsed by the limited eﬃcacy of anti-inﬂammatory
drug therapy of tendinopathy [43].
Bone formation can occur at enthesis (enthesophyte)
sites in tendinopathy disorders and diﬀers from normal frac-
ture healing [41]. Enthesophytes have been shown to form
in regions of high tensile forces, thereby increasing contact
surface area between the tendon or ligament and bone [44,
45]. Anatomical connections from entheses to neighboring
synovium and bone may explain how chronic biomechanical
stress at these sites may lead to secondary histopathology in
AS, including synovitis and bone marrow edema [44–46].
10.ClinicalandCytokineParallelsin
Tendinopathy andAnkylosingSpondylitis
Mechanical forces interacting with cytokines, such as TGF-β
and IL-1β, can stimulate extracellular matrix (ECM) gene
and protein expression, leading to either anabolic or cata-
bolic pathways [47]. Excessive mechanical forces may result
in tissue microinjury in tendinopathy and in AS. Such stress-
mediatedprocessescouldactivateinﬂammatoryresponsesby
release of damage-associated molecules, cytokines, or other
mediators [44, 48]. In overuse tendinopathy, an early in-
crease in proinﬂammatory cytokine levels is believed to
contribute to the observed later-stage degenerative changesArthritis 5
[49]. Few human data are available on cytokine inﬂuences
upon enthesis lesions in AS.
Athletes with symptomatic tendinopathy have been
shown to have stiﬀer Achilles tendons than normal control
subjects [50]. Individuals with diabetes mellitus are also pre-
disposed to the Achilles tendinopathy, possibly related to
structural abnormalities associated with increased stiﬀness
[51]. Perhaps, greater myofascial stiﬀness could generally
predispose individuals to enthesopathy, including tendinop-
athy and AS [13, 15, 37]?
11. Comparison of Demographic Proﬁles and
Implications of Treatment Responses
Similarities in host proﬁles of TP and AS patients could lend
support to biomechanical pathways in both disorders. Over-
all, AS and patellar tendinopathy occur about twice as often
i nm e na si nw o m e n[ 8, 38, 39, 52]. Men have greater mus-
culotendinous stiﬀness than women, which correlated posi-
tively with muscle mass [53]. Men have greater predisposi-
tion to bony tensional attachment injuries, whereas women
are more susceptible to joint instability and intra-articular
injury, such as anterior cruciate ligament (ACL) rupture
[53, 54].
Although inﬂammation is not considered to be the pri-
mary cause of tendinopathy, local morning stiﬀness which
eases with activity is commonly observed [38]. Such symp-
toms are analogous to the pattern of chronic inﬂammatory-
type back pain in AS [55]. Spinal mobility is restricted in
earlyAS[56]andreducedmuscularﬂexibilityisalsothought
to contribute to the development of patellar tendinopathy in
athletic populations [57].
Recommendations formanagementof tendinopathy [13,
43] and AS [58–60] both include physical therapy interven-
tions to maximize the long-term quality of life, although
anti-inﬂammation therapy has an added, relatively greater
beneﬁtinASthanintendinopathy[11,58].Thecombination
of regular, active exercise and pharmacological treatment
has been shown to be more eﬀective in the long-term than
usual therapy in AS [59]. Thus, physical rehabilitation ap-
proaches are beneﬁcial in both conditions. The diﬀerence
in beneﬁts from anti-inﬂammatory therapy between TP and
AS may reﬂect relative degrees of biomechanical versus im-
munological pathways in the respective conditions [10, 11].
If increased axial myofascial tonicity is conﬁrmed in AS
[10, 22, 23], then the transmitted enthesis tissue stiﬀness
could result in greater microinjury. Such pathway deserves
further investigation and is consistent with beneﬁcial results
ofstructuredrehabilitationinterventionsinAS,suchasglob-
al postural reeducation [61] and active exercise treatments
[59].
12.Mechanobiology and
Immunobiology InteractionsinAnkylosing
Spondylitis:Figure2
Trauma was proposed as a possible initiating stimulus for
chronic interactions of the innate and adaptive arms of the
immune system in spondyloarthritis (SpA) and AS [14, 48,
62]. Tissue microinjury could locally activate the innate
immune system by release of damage-associated molecules,
cytokines, or other mediators [44, 45, 62]. In normal sub-
jects, proinﬂammatory cytokine release is increased in skele-
tal muscle following eccentric exercise [63]. However, in the
same normal subjects, a circulating systemic proinﬂamma-
tory response is not seen, possibly due to activation of anti-
inﬂammatory cytokines [63].
We agree with others [14, 48, 64] that microtrauma and
biomechanical stress may be important initiating triggers
and chronic perpetuating stimuli in AS. Our hypothesis of
an innate axial (spinal) myofascial hypertonicity [10, 15, 16]
provides a theoretical framework for increased axial stiﬀness
inAS.Inturn,itcouldpredisposetoexaggeratedstresstrans-
missions through entheses, leading to greater micro-damage
a n da b n o r m a lt i s s u er e p a i rr e s p o n s e s[ 15, 16, 47]. A con-
stitutional biomechanical diathesis, in combination with a
proinﬂammatory predisposition and other genetic factors,
could initiate and perpetuate inﬂammation as well as osteo-
proliferation (syndesmophyte) formation in the AS patient
(Figure 2)[ 16, 64, 65].
Mechanotransduction translates intrinsic and extrinsic
forces into cellular and molecular responses [18, 47, 66]. Ac-
cordingly, cells modify their responses to varied stress by
mechanobiology pathways [66]. Increased structural and
entheseal stresses on extracellular matrix (ECM), tendon,
and bone [16, 66] of AS patients could be expected to result
in altered and pathological tissue responses [15, 16, 37, 44,
66].Inaninvivorodenttendonmodel,mechanicalstresscan
alter the expression of IL-1β in a load-dependent fashion
[67]. In bone, osteoblasts are also load-sensitive cells and can
produce bone morphogenic proteins (BMPs) [66], which
were found to be increased in a murine model of ankylosing
enthesitis [64, 68]. Moreover, microtrauma can release car-
tilaginous molecules that activate inﬂammation by pattern
recognition receptors [48, 69]. Those released ECM frag-
ments can be incorporated intracellularly and initiate a
proinﬂammatory cascade [69].
13. Complex Interactionsof Wnt, DKK-1,
BMPs, andTNF inMurineModels
Investigation into TNF mechanisms in the complex bony
proliferation process has revealed relations to other molecu-
lar pathways. The Wnt family members are relevant, as some
induce diﬀerentiation of osteoblasts and block osteoclast
activity, resulting in a net gain of bone [70]. Dickkopf-1
(DKK-1) is an antagonist of the Wnt/β-catenin bone-form-
ing pathway. Excess TNF, as commonly occurring in AS pa-
tients, has been found to stimulate the production of DKK-1
[71].Inamurineinﬂammatoryarthritismodel,DKK-1inhi-
bition reversed bone erosion into osteophyte formation, sug-
gesting that DKK-1 is an important inhibitory molecule in
bone formation [71]. Another study found increased serum
DKK-1 levels in AS patients treated with anti-TNF agents as
comparedtorheumatoidarthritis patients andnormals[72].
These ﬁndings indicate a paradox in the osteoproliferation
mechanisms in AS.6 Arthritis
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Figure 2: A theoretical outline of immunobiology and mechanobi-
ology processes interacting in initiation and perpetuation of path-
ways in ankylosing spondylitis. (Reproduced with permission for
reprinting from the Journal of Rheumatology; the original was
published as a Figure in [10], A. T. Masi, 2011; 38 (10): (pp. 2092–
2094)).
The TNF-brake hypothesis [73]m a yo ﬀer a possible ex-
planation of the bony proliferative process in AS. It proposes
that, after TNF blocking agents are administered, the DKK-1
is less stimulated by TNF, and then Wnt family members are
less inhibited, permitting increased bony proliferation [73].
Ithasbeenfurtherproposedthat,withincreaseofWntmem-
ber signaling, DKK-1 may be increased as a feedback balanc-
ing response [72].
Bone morphogenetic proteins (BMPs) also have a role
in osteoproliferation. The BMPs control bone growth and
are inhibited by noggin gene transfer [68]. TNF can also
stimulate certain BMPs [68]. Accordingly, overexpression of
BMPs may stimulate greater bone formation at damage sites
and may contribute to osteophyte formation [74]. Since AS
patients may have increased TNF levels, BMP could be up-
regulated and may contribute to bony proliferation. One
study found a nonsigniﬁcant increase in serum BMP-7 levels
in AS patients [75],and increased serum levels ofBMP-2 and
BMP-7 were found in another study of AS patients [76].
14. MechanicalStress Activation of
Inﬂammatory Pathways
Mechanical stress can become translated to inﬂammation
and cellular responses via molecular induction pathways
[18, 47, 66]. Cyclooxygenase-2 (Cox-2) can be induced by
mechanical stress, which leads to increased prostaglandin E2
(PGE2) synthesis in cartilage, as commonly seen in OA [77].
Also,theintracellularNALP3pathwaycantranslatemechan-
ical or metabolic stimuli into cellular responses [69]. In this
pathway, mechanical or metabolic stress can release molecu-
les related to cellular damage. These cellular stress molecules
can be sensed by membrane receptors or be endocytosed,
leading to NALP3 activation. This molecule is part of the
nucleotide-binding domain, leucine-rich repeat containing
family [69]. It is related to increases in proinﬂammatory
cytokines, such as TNF [69]. This pathway culminates in
increased levels of the proinﬂammatory cytokine, interleu-
kin-1β [69].
These Cox-2 and NALP3 transduction pathways may
possibly explain how increased mechanical loading may lead
to inﬂammation and bony proliferation. Both pathways in-
duce increased proinﬂammatory cytokine release [69, 77]
and are consistent with increased BMP upregulation. In a
review, Lories et al. [64] proposed that TNF stimulates BMP
and DKK-1. While DKK-1 inhibits osteoblast diﬀerentiation
bysuppressingWntfamilymembers,theBMPaugmentation
may be an even greater stimulus for bone formation [64].
One study indicated that anti-TNF treatment was more clin-
ically eﬀective in patients with shorter disease duration [78].
It was suggested that disease modiﬁcation is required at the
earliest stages possible to avoid increased levels of BMP or
sensitization to Wnt members and greater osteoproliferation
[78].
Recent research has indicated that tissue inﬂammatory
reactions, as is found in rheumatoid arthritis (RA) and in AS
lesions, can result from nonspeciﬁc cytokine stimulation, in-
cludingT-helpercellactivation[79].Accordingly,suchtissue
reactions need not to be autoimmune nor dependent upon
speciﬁc antigen activations. Rather, such inﬂammatory reac-
tions in these diseases may be initiated and contributed by
cytokines, possibly released from micro injury contributed
byaninnatebiomechanicaldiathesis.Insuchscenario,exces-
sive axial HRMT could be a structural body variant that may
predispose to enhanced entheseal microinjury and initiation
of inﬂammatory pathways [10, 15]. Of potential interest,
a recent report indicated marked (up to 100-fold) upregu-
lation of gene transcripts related to myocyte/myoﬁbroblast
biologyinsynovialtissuesamplesfromSpAversusRAarthri-
tis patients, which suggested structural remodeling mecha-
nisms in SpA [80].Arthritis 7
15.Signiﬁcanceof Researchon AxialHRMT
andC riticalBarrie rst oP r ogr ess
Myofascial tone is literally the tension or stiﬀness of these
specialized tissues which is universally recognized to accom-
pany movements and resistive activities. In the axial (spinal)
system,myofascialtoneistheprimarycontributortostability
in various postural activities, far greater than the osteoliga-
mentous component [15, 20]. Myofascial tone exists in the
body, whether it is (1) passive or active (2) in postural bal-
ance or unbalanced, and (3) static (resting) or in motion.
Accordingly, the body may be considered as being in a pre-
stressedarchitecturaldesign,whichislabeledasbiotensegrity
[17, 18]. Notably, myofascial tone may encompass intrinsic
passivepropertiesofthetissuesaswellasanactivecontractile
component which is superimposed under the control of
the central nervous system (CNS) [15, 19–21]. The passive,
resting (static) tone is independent of CNS control. It results
from the elastic mechanical properties of the stable cross-
bridges between the actin and myosin ﬁlaments of muscle
ﬁbers and the integrated connective tissue ﬁlaments [15, 20,
21].
A critical problem in the interpretation of clinical studies
of HRMT has been the diﬀerentiation of the static, passive
condition alone from any additional low-level contraction
superimposed by CNS activation [81]. Such confounding
of the passive properties by the low-level active contraction
component has led to confusion and misinterpretation in
studiesofthehumanphysiologyandclinicalrelevanceofmy-
ofascial tone [15, 20, 21]. We endorse research to accurately
characterize the low-level, passive biomechanical properties
of axial HRMT (EMG-silent) in relation to AS risks. The
intrinsic HRMT viscoelastic property is a vital body trait
which has been overlooked [82] or misinterpreted [15, 20,
21]. Current lack of conﬁrmed quantitative data on individ-
ualvariability(polymorphism)ofaxialHRMTnowwarrants
critical study of its physical properties and relevance to body
biomechanics in AS.
16.QuantifyingAxialHRMT (EMG-Silent)
Emerging methodological techniques can noninvasively
quantifytheviscoelastic(elasticity,stiﬀness,andtension)pro-
perties of myofascia at precise body levels. Such measure-
ments have not yet been reported at the lumbar level. Con-
current surface electromyography (sEMG) should be per-
formed at the measurement loci to conﬁrm the passive status
and absence of superimposed CNS activation. Extensive data
exist on spinal muscle properties in various degrees of acti-
vated contraction, but none for comparison at rest [82].
The lumbar spine is stabilized and moved by sets of mus-
cles that have varying biomechanical roles [15, 83]. The core
muscles provide mainly segmental stability, whereas more
peripheral muscles control mainly global movements and
activestabilizationofthetrunk[15,83,84].Baseduponsuch
biomechanical principles, our hypothesis is that the core
muscles, for example, lumbar multiﬁdus, will contribute
mainly to variability in innate spinal myofascial stiﬀness
among individuals (polymorphism). Some polymorphic
variation is also expected in the more superﬁcial muscle net-
works, for example, erector spinae.
Techniques have existed that can quantify muscle tone
[81, 85]. However, they are basically dynamic, operating at
macroanatomical levels via imposed passive joint move-
ments (calf, thigh, or the trunk). Emerging technology, like
the Myoton instrument [86, 87] and ultrasonic shear wave
elastography [50, 88–90] will enable noninvasive quantiﬁca-
tion of resting muscle properties of elasticity, stiﬀness, and
tension at precise lumbar anatomical levels. The Myoton
range of depth measurements is mainly limited to several
centimeters within the more superﬁcial muscles, for exam-
ple, erector spinae. Ultrasonic shear wave elastography tech-
nique will be required to measure the deeper or core lumbar
muscles,forexample,themultiﬁdus[90].Theuseofseparate
measurement techniques on the superﬁcial (Myoton and
elastography)anddeeper(elastography)lumbarmuscleswill
aid in interpreting the respective ﬁndings.
Cross-sectionalanalysisofaxialHRMTcouldtestwheth-
er or not AS patients have greater lumbar myofascial biome-
chanical properties of stiﬀness/tension than normal subjects
or even greater than patients with non-AS chronic, mechan-
ical low-back disorders [15]. The ultrasonic shear wave elas-
tography technique is able to scan deeply into the dorsolum-
bar myofascial tissues to investigate viscoelastic properties
of the multiﬁdus at the L3-L4 level and of its enthesis sites.
Theseviscoelasticpropertieshavenotbeenreportedandmay
become valuable as a biomarker in an earlier diagnosis of
AS. Cost-eﬀective biomechanical criteria for AS have not yet
been investigated, which may help to identify its early stage
[22, 23]. Viscoelastic properties may have utility in also help-
ing to identify asymptomatic high-risk susceptibles who may
belikelytodevelop AS,suchasthoseHLA-B27-positive ﬁrst-
d e g r e er e l a t i v e so fA Sp r o b a n d s[ 15].
17.TechnicalInnovationIsNeededto
Quantify Biomechanical Inﬂuences on AS
Interdisciplinary biomechanical approaches are needed to
quantify and analyze passive (EMG-silent) axial (spinal) my-
ofascial tone in normal subjects, patients with AS, and those
withotherchronicLBPconditions.Quantitativebiomechan-
ical study is needed to analyze individual variability char-
acteristics (polymorphisms) of the hardly appreciated axial
HRMT trait in large samples of healthy persons. Such studies
will reveal and elucidate the signiﬁcance of resting axial
muscle tone in the spinal musculoskeletal system.
When axial (and general body) passive tone and stiﬀness
arenormallysuﬃcient,thistraitisbiomechanicallyandmet-
abolically eﬃcient in energy expenditure [19]. Insuﬃcient or
excessive axial HRMTs are likely to have physical penalties,
like increased risks of developing spinal consequences [24]
and possible energy metabolic impacts [19]. Axial HRMT is
a macrostructural component of the body tensegrity design
[17–19]. Incorporation of tensegrity [17–19]c o n c e p t sa n d
utilization of structural mechanical modeling [35] promises
to enhance understanding of spinal disorders, like AS.8 Arthritis
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